No Data
No Data
Top Executive Sells Millions in Elevance Health Stock!
Argus Research Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $465
Trump Likes Concept of Millionaire Tax, Would Veto Medicaid Cuts - Report
A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $478 to $585
'Medicaid to the Rescue,' Says Wall St. Analyst About Elevance Health (ELV) Stock
Elevance Health's Growth Potential Justifies Buy Rating Amid Sector Challenges